A B S T R A C T The low thyroxine (T4) state of acute critical nonthyroidal illnesses is characterized by marked decreases in serum total T4 and triiodothyronine (T3) with elevated reverse T3 (rT3) values. To better define the mechanisms responsible for these alterations, serum kinetic disappearance studies of labeled T4, T3, or rT3 were determined in 16 patients with the low T4 state and compared with 27 euthyroid controls and a single subject with near absence of thyroxine-binding globulin. Marked increases in the serum free fractions of T4 (0.070±0.007%, normal [nl] 0.0315±0.0014, P <0.001), T3 (0.696±0.065%, nl 0.310±0.034, P <0.001), and rT3 (0.404±0.051%, nl 0.133±0.007, P < 0.001) by equilibrium dialysis were observed indicating impaired serum binding. Noncompartmental analysis of the kinetic data revealed an increased metabolic clearance rate (MCR) of T4 (1.69±0.22 liter/d per m2, nl 0.73±0.05, P < 0.001) and fractional catabolic rate (FCR) (32.8±2.6%, nl 12.0±0.8, P < 0.001), analogous to the euthyroid subject with low thyroxine-binding globulin. However, the reduced rate of T4 exit from the serum (Kii) (15.2±4.6 d-1, nl 28.4±3.9, P < 0.001) indicated an impairment of extravascular T4 binding that exceeded the serum binding defect. This defect did not apparThis work was presented in part at the 6th International Congress of Endocrinology, Melbourne, Australia, February, 1980 (Abstract No. 364), and at the 61st Annual Endocrine Society Meeting, Wash., D. C., June, 1980 These alterations in thyroid hormones indices and kinetic parameters for T4, T3, and rT3 in the low T4 state of acute nonthyroidal illnesses can be accounted for by: (a) decreased binding of T4, T3, and rT3 to vascular and extravascular sites with a proportionately greater impairment of extravascular T4 binding, and (b) impaired 5'-deiodination activity affecting both T4 and rT3 metabolism.
A B S T R A C T The low thyroxine (T4) state of acute critical nonthyroidal illnesses is characterized by marked decreases in serum total T4 and triiodothyronine (T3) with elevated reverse T3 (rT3) values. To better define the mechanisms responsible for these alterations, serum kinetic disappearance studies of labeled T4, T3, or rT3 were determined in 16 patients with the low T4 state and compared with 27 euthyroid controls and a single subject with near absence of thyroxine-binding globulin. Marked increases in the serum free fractions of T4 (0.070±0.007%, normal [nl] 0.0315±0.0014, P <0.001), T3 (0.696±0.065%, nl 0.310±0.034, P <0.001), and rT3 (0.404±0.051%, nl 0.133±0.007, P < 0.001) by equilibrium dialysis were observed indicating impaired serum binding. Noncompartmental analysis of the kinetic data revealed an increased metabolic clearance rate (MCR) of T4 (1.69±0.22 liter/d per m2, nl 0.73±0.05, P < 0.001) and fractional catabolic rate (FCR) (32.8±2.6%, nl 12.0±0.8, P < 0.001), analogous to the euthyroid subject with low thyroxine-binding globulin. However, the reduced rate of T4 exit from the serum (Kii) 23 .47+2.12, P < 0.005) appeared to result from reduced peripheral T4 to T3 conversion because of decreased 5'-deiodination rather than from a decreased T4 availability. This view was supported by the normality of the rT3 production rate. The normal Kii values for rT3 indicated a comparable defect in serum and extravascular rT3 binding. The reduced MCR (25.05±6.03 liter/d per m2, nl 59.96±8.56, P < 0.005) and FCR (191.0±41.19%, nl 628.0±199.0, P < 0.02) for rT3 are compatible with an impairment of the rT3 deiodination rate.
These alterations in thyroid hormones indices and kinetic parameters for T4, T3, and rT3 in the low T4 state of acute nonthyroidal illnesses can be accounted for by: (a) decreased binding of T4, T3, and rT3 to vascular and extravascular sites with a proportionately greater impairment of extravascular T4 binding, and (b) impaired 5'-deiodination activity affecting both T4 and rT3 metabolism. roxine (TT4)' in association with normal serum thyrotropin (TSH) levels (1) (2) (3) (4) (5) . In addition, total serum triiodothyronine (TT3) levels are decreased, and total reverse T3 (TrT3) values are usually increased (1, [3] [4] [5] , as in other nonthyroidal illnesses (6) (7) (8) (9) .
Despite the reduced circulating levels of TT4 in these patients, free T4 concentrations by equilibrium dialysis (FT4D) (1, 5) and T4 production rates (5) are usually normal. The low TT4 values have been attributed to an acquired defect of serum T4 binding (1, 5) , possibly secondary to a nondialyzable serum inhibitor (10) . Such a defect is compatible with the shortened residence time (t) and accelerated metabolic clearance rates (MCR) for labeled T4 observed in these patients (5) . Other kinetic parameters of T4, as well as those for T3, and rT3 have not been described in patients with the low T4 state of nonthyroidal illnesses.
The present study was undertaken to examine, by noncompartmental analysis, the pattern of alterations occurring in binding, distribution, production, and disposal of T4, T3, and rT3 during the low T4 state of acute nonthyroidal illnesses.
METHODS
The study population consisted of 16 (11, 12) , dilantin (13) , or heparin (14, 15) were excluded as were patients with known or suspected hypothalamic or pituitary disease, head trauma (16) , thyroid disease, or recent thyroid (17) or glucocorticoid hormone therapies (18, 19 Table II .
The kinetic parameters were calculated using noncompartmental analysis (21, 22 (24, 25) . The serum TSH concentrations were measured by a commercial method (Abbott Diagnostics, Diagnostic Products, North Chicago, Ill.). Free T4 levels were determined by equilibrium dialysis (FT4D) (26) courtesy of Nichols Institute, San Pedro, Calif. Free T3 and rT3 were also measured by equilibrium dialysis (26, 27) with purification of the tracer by polyacrylamide gel filtration before dialysis (28) , and of the dialysate by resin after dialysis (29) . All free hormone levels were determined on 0 time samples. Serum TBG levels were measured by radioimmunoassay (30) courtesy of Nichols Institute.
All results are expressed as a mean±1 SEM. The data were analyzed for significance using unpaired Student's t test for unpaired data with equal and unequal variances or unpaired ranked sum test (31) . Correlation matrices were calculated using programs from the Biomedical Data Processing package (32). 
RESULTS
The mean serum disappearance curves for labeled T4, T3 and rT3 of the study patients and the normal subjects are shown in Fig. 1 and Table II and the noncompartmental parameters are summarized in Tables  III-V . The pattern of serum disappearance of T4 during the first 24 h in the patients was similar or slower than in the normal subjects, while the subsequent disappearance rate was greater in the patients. The disappearance patterns of T3 were similar in both groups during the early and late phases. In contrast, the mean rT3 disappearance curve in the patients was retarded throughout the study period relative to the control group.
It is evident from Fig. 1 that the serum disappearance curves for both the normal subjects and the patients did not fit 1 exp. and 4 exp were not required to describe the curves for any of the individuals studied. Indeed, these curves were best described by the sum of 3 exp in 20 of 30 subjects for T4, in 14 of 17 for T3, and in 12 of 15 for rT3. The disappearance curves in the remaining subjects best fit the sum of 2 exp. The numbers of curves fitting 2 or 3 exp in the two groups were not significantly different when compared by Fisher's exact test (33) .
During the time of the T4 tracer studies in the patients, the serum TT4 concentrations remained stable with a mean of 1.7±0.2 yg/dl at time 0, 1.8±0.2 gg/ dl at 48 h, and 1.8±0.3 tg/dl at 96 h of the study. Despite the markedly decreased serum TT4 values, the FT4D were within the normal range in 8 of 11 patients (Table III) . This was secondary to an increased percent free fraction of T4 (FFT4). There were no significant correlations among these parameters. In comparison, a markedly decreased serum level of TT4 with an increased FFT4 was also noted in the one healthy euthyroid subject with near absence of TBG. noted between the dopamine-treated and untreated tabolism of T4, T3, and rT3 during the low T4 state of patients (Table V) . acute critical nonthyroidal illnesses. These alterations are presumably responsible for the decreased serum DISCUSSION levels of TT4 and TT3 and for the elevated levels of TrT3 observed in these patients. It should be emphaThe results of the present study demonstrate that mul-sized that the magnitude of the changes in the serum tiple alterations occur in the peripheral hormone me-levels and the kinetic parameters were similar within this patient group, despite a marked variation in the underlying diagnoses. This included the dopaminetreated patients in whom the only difference was a lower T4 PR and pool size. This uniformity suggests that the factors responsible for these alterations may be similar. The disturbances in thyroid hormone kinetic parameters could, theoretically, result from abnormalities of intravascular and extravascular binding and distribution, as well as of hormone production and disposal.
The marked reduction of T4, T3, and rT3 binding to serum carrier proteins in the low T4 state was one of the most consistent findings of the present study. This alteration was principally manifested by the twoto fourfold increase in the percent free fraction (FF) values for T4, T3, and rT3 as determined by equilibrium dialysis. This finding has been previously reported in a variety of acute and chronic nonthyroidal illnesses (27) . The reduced serum binding could be due to decreased serum concentration and/or affinity of TBG. Serum TBG levels by radioimmunoassay were available in patients 4, 5, and 6 of the present study and the values were 2.7, 1.3 and 2.9 mg/dl (normal range: 1.7-5.1 mg/dl). Similar TBG levels were observed in two other comparable groups of critically ill patients with nonthyroidal illnesses who had serum TT4 levels below 3 ,tg/dl (5, 34 (35) , as well as the low TBG patient whose kinetic parameters were evaluated as part of this study (Table III) . In addition, the decreased serum binding of T4 should permit an accelerated Kii as seen in our one patient with a low TBG concentration, and as previously reported (36, 37) . However, our data show that Kii was significantly retarded in patients with the low T4 state suggesting impaired egress of T4 from serum.
The decrease in the rate of T4 egress from serum could result from (a) reduced activity of a specific transport system for T4, (b) impaired extravascular T4 binding or (c), an increased serum concentration of a compound(s) that competes with T4 for either trans (35, 37) .
The increased FFT3 observed in our patients and in other nonthyroidal illnesses (27) suggests a decreased binding of T3 to serum proteins. This abnormality could account for the accelerated MCR and increased TVD, which are also seen in healthy euthyroid individuals with low concentrations of TBG (35, 45) . Because one would expect Kii to be enhanced in the presence of decreased serum T3 binding (45) , the normal Kii values in our patients suggest a comparable defect in serum and extravascular binding.
The T3 PR was markedly reduced in our patients, which is a feature common to other nonthyroidal illnesses (6) (7) (8) . T3 production could be reduced as a result of decreased free T4 availability or to impaired enzymatic deiodination of T4. Because both, the T4 PR and free T4 levels were in the low normal range in these patients, reduced T4 availability would not appear to be a major factor. Furthermore, the reduction in the T3 PR to 27±2% of the normal mean was significantly (P < 0.01) greater than the decrease in T4 PR of 56±7% suggesting that impaired deiodination of T4 to T3 was involved. In vitro data indicate that the 5'-deiodinase activity may be reduced in nonthyroidal disorders (44) ; however, the extent to which these factors contribute to the decreased T3 PR in vivo is not defined.
The binding of rT3 to serum carrier proteins also appeared to be impaired since the FFrT3 in our patients was increased as has been reported in other nonthyroidal illnesses (27) . The finding that Kii was normal in the face of decreased serum binding is compatible with a comparable decrease in serum and tissue rT3 binding. An alternate explanation for these changes might be an impaired transport of rT3 into tissues. This should result in reduced MCR, FCR, and FDR values for rT3. Indeed, MCR and FCR are reduced but FDR values are essentially normal, making this possibility unlikely. Similar kinetic alterations for rT3 have been reported in nonthyroidal illnesses by Chopra et al. (9) and in fasting (46) and have been attributed to impaired 5'-deiodination of rT3. An abnormality in this enzyme step could account for the reduced production of T3 from T4 as well as the impaired MCR and FCR of rT3 in our patients.
The results of the present study indicate that two major abnormalities could account for the disturbances in T4, T3, and rT3 metabolism present in patients with the low T4 state of nonthyroidal illnesses. These include decreased binding of T4, T3, and rT3 to both vascular and extravascular sites, and impaired 5'-deiodination of T4 to T3.
